clinical-trials-2017-scientifictracks-abstracts

29 / 46

Page 70
Notes:
conferenceseries.com
Volume 7, Issue 5 (Suppl) J Clin Trials, an open access journal
ISSN:2167-0870 Clinical Trials 2017
September 11-13, 2017
September 11-13, 2017 San Antonio, USA
4th International Conference on
Cl inical Tr ial s
The good, the bad, and the unknown of executing clinical trials in Mexico and LatinAmerica
Sergio Guerrero
Universidad Autonoma de Ciudad Juárez, México
The globalization of R&D into emerging regions has continue to grow more in the last decade in Latin America, driven
by many factors including improved regulatory environment, commercial markets, favorable economics with lower
relative costs, access to highly skilled professional and a large pool of patients in the region. But, now with a better established
atmosphere and a strong healthcare infrastructure, Latin America offers a number of advantages as a location for clinical
trials, and at the same time, the region presents other challenges particularly related to the industry that must be anticipated
and managed appropriately, because we still confronting significant logistical battles and delays in implementing clinical trials
in the region due to improper planning of the developments by the industry, that potentially could interfere with any new
regional improvements and potentially interrupt results. If the clinical research industry is willing to take the moment and
better understand their processes adapting new approaches to support an efficient global drug development program in the
region, the results can be notable on time and manner. This session is intended to analyze key issues, opportunities (Good),
challenges (Bad) and the unknown of doing clinical trials implementation in Latin America, and to review and understand a
better planning when selecting the Latin American region to participate in a Global Clinical Trial.
Biography
Sergio Guerrero received his Medical Degree from the School of Medicine of the Universidad in Juarez, Mexico. He initiated his Medical research career in
Bethesda, MD (USA) participating in the transplant research technology that later lead him to manage the operation according to the Food and Drug Administration
of the United States. In the last 20 years, he dedicated to the organization, managing and conducting clinical trials in the US and Latin American region for the
international pharmaceutical industry on new drug/medical devices development according to US FDA, ICH/GCP guidelines, EMA, and local regulations. For
numerous years, he worked as Director of a Clinical Research Center in Mexico where he managed a multispecialty medical group and investigators in the conduct
of clinical trials phase I-IV. Presently, he is responsible for the Operations of a CRO in Mexico.
Sergio Guerrero, J Clin Trials 2017, 7:5 (Suppl)
DOI: 10.4172/2167-0870-C1-019